Skip to content
lifestyle.bossesmag.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
OXB
OXB Capital Markets Event
June 2, 2026
OXB to exhibit and present at the 30th Annual Meeting of the American Society of Cell and Gene Therapy (ASGCT)
May 29, 2026
OXB launches fast-track offering for AAV and lentiviral vector platforms, accelerating viral vector development and manufacture
May 24, 2026
OXB recognised as ‘Most Innovative CDMO (Cell & Gene)’ at 2026 CDMO Leadership Awards
May 22, 2026
Preliminary results for the year ended 31 December 2025
May 22, 2026
OXB enters into licensing agreement with Viral Vector Manufacturing Facility (VVMF), providing access to its AAV and LV viral vector platforms
May 20, 2026